"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"
- Starts: 1:45 pm on Friday, October 12, 2012
- Ends: 2:45 pm on Friday, October 12, 2012
Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD
Director of Developmental Therapeutics
Massachusetts General Hospital Cancer Center
Harvard Medical School
- Location:
- 670 Albany Street Room #107/108
- Link:
- http://www.bumc.bu.edu/busm-pathology/files/2008/09/Seminar-Fall-2012.pdf
- Contact Name
- Deb Kiley
- Information Phone
- 617 414 7914
- Contact Email
- debra.kiley@bmc.org
- Show Contact
- yes